Journal list menu
Export Citations
Download PDFs
Issue Information – Table of Contents
Editorial Perspective
Free Access
free
Clinical pathways in chronic lymphocytic leukemia: Challenges and solutions
- Pages: 5-6
- First Published: 20 October 2016
Research Articles
Free Access
free
Buparlisib, a PI3K inhibitor, demonstrates acceptable tolerability and preliminary activity in a phase I trial of patients with advanced leukemias
- Pages: 7-11
- First Published: 27 September 2016
Free Access
free
Fludarabine and cytarabine versus high-dose cytarabine in consolidation treatment of t(8; 21) acute myeloid leukemia: A prospective, randomized study
- Pages: 12-17
- First Published: 27 September 2016
Free Access
free
Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia—A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
- Pages: 18-22
- First Published: 27 September 2016
Free Access
free
A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study)
- Pages: 23-27
- First Published: 03 October 2016
Free Access
free
Chronic granulomatous disease: Clinical, functional, molecular, and genetic studies. The Israeli experience with 84 patients
- Pages: 28-36
- First Published: 04 October 2016
Free Access
free
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients
- Pages: 37-41
- First Published: 04 October 2016
Free Access
free
Reduced intensity conditioned allograft yields favorable survival for older adults with B-cell acute lymphoblastic leukemia
- Pages: 42-49
- First Published: 06 October 2016
Open Access
oa
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation
- Pages: 50-55
- First Published: 12 October 2016
Free Access
free
DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemia
- Pages: 56-61
- First Published: 12 October 2016
Free Access
free
The use of biomarkers to describe plasma-, red cell-, and blood volume from a simple blood test
- Pages: 62-67
- First Published: 13 October 2016
Free Access
free
Oncogenic events rather than antigen selection pressure may be the main driving forces for relapse in diffuse large B-cell lymphomas
- Pages: 68-76
- First Published: 13 October 2016
Free Access
free
Hydroxyurea effectiveness in children and adolescents with sickle cell anemia: A large retrospective, population-based cohort
- Pages: 77-81
- First Published: 19 October 2016
Free Access
free
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line
- Pages: 82-87
- First Published: 22 October 2016
Critical Review
Free Access
free
Management of anemia in patients with congestive heart failure
- Pages: 88-93
- First Published: 25 October 2016
Annual Clinical Updates in Hematological Malignancies: A Continuing Medical Education Series
CME Information: Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification and management
Free Access
free
Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management
- Pages: 94-108
- First Published: 19 December 2016
Clinical Pearls in Blood Diseases
Morphology Update
Free Access
free
Cold autoimmune hemolytic anemia secondary to atypical pneumonia
- Page: 109
- First Published: 06 September 2016
Solving Clinical Problems in Blood Diseases
Test of the Month
Free Access
free
Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand disease
- Pages: 114-118
- First Published: 13 September 2016
Images in Hematology
Free Access
free
Mixed angioinvasive exserohilum and scedosporium infection in a patient with AML
- Pages: 119-120
- First Published: 24 June 2016
E-ONLY Articles
Correspondence
Free Access
free
CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?
- Pages: E1-E2
- First Published: 03 October 2016
Free Access
free
Hereditary persistence of fetal hemoglobin in two patients with KLF1 haploinsufficiency due to 19p13.2–p13.12/13 deletion
- Pages: E2-E3
- First Published: 04 October 2016
Free Access
free
Clinical characteristics of Philadelphia positive T-cell lymphoid leukemias—(De novo and blast phase CML)
- Pages: E3-E4
- First Published: 11 October 2016
Free Access
free
The effect of arterial hypertension on thrombosis in low-risk polycythemia vera
- Pages: E5-E6
- First Published: 13 October 2016
Free Access
free
Concurrent STAT3, DNMT3A, and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential
- Pages: E6-E8
- First Published: 19 October 2016
Free Access
free
Improved outcomes in acute myeloid leukemia patients treated with washed transfusions
- Pages: E8-E9
- First Published: 19 October 2016
Open Access
oa
Treatment of central venous catheter-associated deep venous thrombosis in cancer patients with rivaroxaban
- Pages: E9-E10
- First Published: 20 October 2016
Free Access
free
Effects of hydroxyurea on F-cells in sickle cell disease and potential impact of a second fetal globin inducer
- Pages: E10-E11
- First Published: 20 October 2016
Free Access
free
Repeated loss of target surface antigen after immunotherapy in primary mediastinal large B cell lymphoma
- Pages: E11-E13
- First Published: 25 October 2016